尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the full record of transactions filed by Gray Mary Ann. Insider active across 5 companies, notably Sarepta Therapeutics, Inc.. Cumulatively, 18 reports have been logged. History available since 10 December 2021. The latest transaction was filed on 30 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 条申报中的 18 条
GRAY MARY ANN is a declarant associated with DYAX CORP, BioAtla, Inc., RAPT Therapeutics, Inc., Sarepta Therapeutics, Inc. and Keros Therapeutics, Inc. She is listed as Director at BioAtla, Inc., RAPT Therapeutics, Inc., Sarepta Therapeutics, Inc. and Keros Therapeutics, Inc. The record shows 18 filings, with recent filings dated from 2016-01-19 to 2026-03-05, and the stated transaction nature is Attribution.